|1)||Market survey and demand|
|2)||Screening target drugs
(Oral reference drug)
|T.I.D dosage tablet (100mg)|
|4)||Designing target drug||Weekly dosage patch (50mg)
|6)||Decision on target drug design||Weekly dosage patch (100mg)
|7)||Pre-clinical & Clinical studies,
Approval on marketing authorization
* Sinil is able to tie up with partners from at any steps.
* Sinil would prefer to do co-development from the initial stage with partners.
* Ex.) MIAT performs Step 1 ~ 2
Sinil performs Step 3 ~ 5
* Proposal form for Co-Development